Ophthalmic presentations and outcomes in Erdheim-Chester disease
4 December 2023
| Hetvi Bhatt
|
Oculoplastics, Orbit
|
Erdheim–Chester disease, orbital Erdheim–Chester disease, vemurafenib
This is a comprehensive article describing clinical manifestations and pathogenesis of Erdheim-Chester disease (ECD) followed by a literature review of the available treatments. The authors look to compare historical treatment (HT) with vemurafenib, a BRAF inhibitor. ECD is a non-Langerhans...
